Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Times Interest Earned (2016 - 2017)

Corcept Therapeutics (CORT) has disclosed Times Interest Earned for 7 consecutive years, with $130.56 as the latest value for Q2 2017.

  • Quarterly Times Interest Earned rose 4497.35% to $130.56 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $705.2 through Mar 2018, up 8036.4% year-over-year, with the annual reading at $4.99 for FY2016, 529.91% up from the prior year.
  • Times Interest Earned hit $130.56 in Q2 2017 for Corcept Therapeutics, up from $21.07 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $130.56 in Q2 2017 to a low of -$12.01 in Q1 2014.
  • Historically, Times Interest Earned has averaged $6.47 across 5 years, with a median of -$1.51 in 2015.
  • Biggest five-year swings in Times Interest Earned: decreased 25.19% in 2014 and later surged 4497.35% in 2017.
  • Year by year, Times Interest Earned stood at -$9.17 in 2013, then skyrocketed by 58.97% to -$3.76 in 2014, then soared by 163.43% to $2.39 in 2015, then surged by 411.86% to $12.21 in 2016, then skyrocketed by 969.11% to $130.56 in 2017.
  • Business Quant data shows Times Interest Earned for CORT at $130.56 in Q2 2017, $21.07 in Q1 2017, and $12.21 in Q4 2016.